Sign in

CIK 0001841330 · <br>Emerging growth company

Pasithea Therapeutics Corp.

Sign in to watch
Ticker
KTTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851591963
Phone
(702) 514-4174
Business address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 10-K/A Report 10-K/A
  4. 424B3 Offering Prospectus
  5. 424B3 Offering Prospectus
  6. 10-K Report Annual Report
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 424B3 Offering Prospectus
  11. 4 Insider Changes in Ownership
  12. 424B3 Offering Prospectus
  13. 8-K Event Executive or director change
  14. 424B3 Offering Prospectus
  15. SC 13G Stake Amended Statement of Ownership
  16. EFFECT Other Notice of Effectiveness
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. UPLOAD Other SEC-generated Letter
  19. S-1 Offering Registration Statement
  20. D Other Notice of Sales of Unregistered Securities

Page 15 of 18 · 344 filings